CoChat

Targeting transgene to the heart and liver with AAV 9 by different promoters

Chen, Bang‐Dang, He, Chun‐Hui, Chen, Xiao‐Cui, Pan, Shuo, Liu, Fen, Ma, Xiang, Li, Xiao‐Mei, Gai, Min‐Tao, Tao, Jing, Ma, Yi‐Tong, Yang, Yi‐Ning, Gao, Xiao‐Ming · 2015 · Clinical and Experimental Pharmacology and Physiology
Cited by 52

The DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.

Abstract

Summary: Adeno‐associated virus (AAV) has become one of the most promising gene transfer tools for gene therapy. This work aims to evaluate tropism, gene transfer efficiency and safety of AAV 9 vectors produced with recombinant baculovirus (rB ac)‐based system. AAV 9‐CMV‐GFP and AAV 9‐CBA‐GFP were produced using a rB ac system, 1 × 10 11 particles of each vectors were administered intravenously (i.v.) into mice and animals were killed at 1, 2, 3, 4, 5 and 8 weeks after administration. The GFP expression in different organs was analyzed by fluorescence imaging and Western blot. Viral genomic quantities were measured using qPCR. In vitro transduction efficiency of AAV 9 vectors in primary cardiomyocytes and hepatocytes was determined by flow cytometry. Toxicity of AAV 9 vectors was evaluated by determining certain cardiac and liver injury biomarkers and renal function test in vivo and TUNEL analysis in vitro. The data showed that AAV 9 viral particles packaged by the rB ac system were fully functional in vivo and in vitro. The CMV promoter predominantly induced higher cardiac GFP transgene expression and DNA copy numbers while the CBA promoter resulted in robust GFP expression and high vector DNA copy numbers in mouse liver, both in a time‐dependent increased manner. Such distinct preferential effects were also observed in the heart and liver as early as 3 and 5 days after co‐infection. Both the AAV 9‐CMV and AAV 9‐CBA viral packages did not induce heart, liver and renal damage and cell apoptosis. These results indicated that AAV 9‐CMV can efficiently and safely direct cardiac gene transfer, whereas AAV 9‐CBA is preferential for liver gene delivery.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1111/1440-1681.12453

Cites

7 of 7 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 7 references

Cited by

See all 52

Metadata

Authors
Chen, B., He, C., Chen, X., Pan, S., Liu, F., Ma, X., Li, X., Gai, M., Tao, J., Ma, Y., Yang, Y., & Gao, X.
Venue
Clinical and Experimental Pharmacology and Physiology
Publisher
Wiley
Published
2015-09-15
Volume
42
Issue
10
Pages
1108-1117
ISSN
  • 0305-1870 (ISSN-L)
  • 1440-1681
OpenAlex
W1907611889
Cited by
52
References
7
FWCI
2.06
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Targeting transgene to the heart and liver with AAV 9 by different promoters. https://app.cochat.ai/papers/10.1111/1440-1681.12453
The paper
Chen, B., He, C., Chen, X., Pan, S., Liu, F., Ma, X., Li, X., Gai, M., Tao, J., Ma, Y., Yang, Y., & Gao, X. (2015). Targeting transgene to the heart and liver with AAV 9 by different promoters. Clinical and Experimental Pharmacology and Physiology. https://doi.org/10.1111/1440-1681.12453

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.